Title: The voltage-gated sodium channel NaV 1.9 in visceral pain.

Authors: J R F Hockley, W J Winchester, D C Bulmer

Journal, date & volume: Neurogastroenterol Motil, 2016Mar, 28, 316-26

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/26462871

Abstract
Visceral pain is a common symptom for patients with gastrointestinal (GI) disease. It is unpleasant, debilitating, and represents a large unmet medical need for effective clinical treatments. Recent studies have identified NaV 1.9 as an important regulator of afferent sensitivity in visceral pain pathways to mechanical and inflammatory stimuli, suggesting that NaV 1.9 could represent an important therapeutic target for the treatment of visceral pain. This potential has been highlighted by the identification of patients who have an insensitivity to pain or painful neuropathies associated with mutations in SCN11A, the gene encoding voltage-gated sodium channel subtype 1.9 (NaV 1.9).Here, we address the role of NaV 1.9 in visceral pain and what known human NaV 1.9 mutants can tell us about NaV 1.9 function in gut physiology and pathophysiology.